Australia

Fri
05
Jan

Harvest One Cannabis stock has plenty of growth potential

Harvest One Cannabis Inc. (TSXV:HVST) is a global cannabis company serving the medical cannabis markets internationally and is preparing to serve the new Canadian recreational cannabis market.

Harvest One Cannabis operates through its two wholly-owned subsidiaries, United Greeneries Holdings Ltd. and Satipharm AG. United Greeneries is based in Vancouver, BC and holds a Canadian ACMPR cultivation and sales license for its 16,000 sq ft facility at Duncan, BC, with 1,000 kg of annual production capacity.

Thu
04
Jan

Australia aims to be world's top medicinal cannabis supplier after exports get green light

Australia’s budding medicinal cannabis sector is set for a major windfall after winning approval to begin exports. The health minister, Greg Hunt, said allowing medicinal cannabis product exports will help the developing domestic market to grow.

“By helping the domestic manufacturers to expand, this, in turn, helps to ensure an ongoing supply of medicinal cannabis products here in Australia,” Hunt said in a statement. He said he hopes Australia can be the world’s top supplier of medicinal cannabis.

The export permit will be done by regulation. The federal government in 2016 legalised patient access to Australian-grown and manufactured medicinal cannabis, subject to state and territory regulations.

Tue
02
Jan

US recreational marijuana laws sparks debate in Australia

Residents in California are welcoming new laws of legalising the recreational use of marijuana yesterday morning.

California is now one of six American states to legalise recreational marijuana use, which means people aged 21 and over no longer require a medical license to purchase and use the drug.

The new law is sparking discussions in Australia on whether we should do the same and what dangers may be involved.

Marijuana advocate Greg Barns said it was inevitable that the laws would eventually change in Australia to make the drug legal.

“There is a global trend now, not just in California, but you will see on July 1 this year, the whole of Canada moving to legalise the personal use of cannabis,” Mr Barns said.

Fri
22
Dec

It’s nearly 2018 and weed is still illegal for recreational use in Australia — this needs to change

AUSTRALIA proved it was open-minded when it came to saying yes to same-sex marriage.

The Yes vote has reason to celebrate, but if we truly are a progressive county like many of you proclaimed on social media, why are we not discussing other outdated practices like the fact weed is still illegal for recreational use in Australia in 2017?

Even though I don’t care for the institution of marriage as a whole, I still voted Yes because I believe, as adults, we should be given the freedom to make our own choices for things that really don’t have a negative impact on the lives of others. And I think weed is one choice.

‘WHAT ARE THE LAWS CURRENTLY IN AUSTRALIA?’

Fri
22
Dec

Canadian Cannabis companies seeking higher stakes in Australian market

As investor excitement continues to climb in Canada over the upcoming legalization of cannabis on July 1, 2018, major Canadian companies are already setting their sights on the next big legal cannabis market—Australia.

Big players in the Canadian cannabis space already have started to stake claims “Down Under” where medical cannabis is beginning to take hold.

These companies include Aurora Cannabis (TSXV: ACB) (OTC: ACBFF), Canopy Growth Inc. (TSX: WEED) (OTC: TWMJF), CannTrust Holdings Inc. (CSE: TRST) (OTC: CNTTF), MedReleaf Corp. (TSX: LEAF) (OTC: MEDFF), and MYM Nutraceuticals Inc. (CSE: MYM) (OTC: MYMMF).

Australian consumers are already undergoing a very quick renaissance into the cannabis market, with several developments happening in the past few months.

Fri
22
Dec

Doctors in Australia given access to clinical information to help with cannabis prescription

Evidence is still not in on medical cannabis for treating certain conditions, according to new guidance documents for doctors and the public.

For the first time, Australian doctors will have access to up-to-date information from a government website to help them decide whether to prescribe cannabis to patients.

The Turnbull Government will today release the documents, which provide clinical information on the effectiveness of medicinal cannabis for five specific conditions.

These are palliative care, multiple sclerosis, chemotherapy-induced nausea and vomiting, chronic non-cancer pain and epilepsy.

Wed
20
Dec

Top Marijuana Stocks to put you in the green

Leslie Bocskor, president of Electron Partners, discussed last year the explosive rise in demand for stocks in Marijuana. Over the next five years, its set to double in value each year as factors change in its favour. Since its legalisation in the US, demand has outstripped demand annually, and states are seeing the financial benefits.

By 2026, the annual value of cannabis worldwide will reach $50 billion according to MarketWatch. The market faces scepticism, but investment remains lucrative for those seeking a growth market. Here are some stocks to consider for putting you in the green.

Marijuana stocks to take your portfolio up

GW Pharmaceuticals – $129.68 (Down 0.41%)

Wed
20
Dec

Aurora Cannabis to make strategic investment in Micron Waste Technologies

Aurora Cannabis Inc. (TSX: ACB) (OTCQB: ACBFF) and Micron Waste Technologies Inc. (CSE: MWM, OTC: MICWF), a developer of proprietary digester solutions for the treatment of organic waste, today announced that the companies have signed a non-binding term sheet for Aurora to make a strategic investment in Micron, and for both companies to collaborate on the optimization of Micron's technology for the treatment of organic waste generated in the cultivation and production of cannabis products.

Wed
13
Dec

Queensland Bauxite’s subsidiary signs deal for cannabis-based pain relief pill

Queensland Bauxite’s (ASX: QBL) 55%-owned subsidiary Medical Cannabis has inked a contract to establish a joint venture with a group of United States chemists who’ve put together a cannabis-based pain relief pill, in what Queensland Bauxite dubs a “world first” for the medical cannabis sector.

Medical Cannabis signed the letter of intent with the Israeli-recommended group, which has created and manufactured a sample range of GMP quality pain relief pills derived from the cannabis plant.

For an initial A$1 million investment, Medical Cannabis will be able to test and exclusively market the pills, which can offer short and extended pain relief, within Australasia.

Tue
05
Dec

Canada's Aurora Cannabis boosts stake in Australia-based Cann Group

Canada’s Aurora Cannabis Inc (ACB.TO) said on Monday it increased its stake in Australia-based Cann Group Ltd (CAN.AX) to 22.9 percent from 19.9 percent, its latest move to expand in the cannabis industry.

Aurora, already Cann Group’s largest shareholder, said it bought the shares at A$2.50 ($1.90) apiece. Shares of Cann Group ended 4.7 percent higher at A$3.14 on the Australian Stock Exchange on Monday.

Cann Group was the first Australian company to receive a license to research and cultivate cannabis for medical purposes.

Pages

Subscribe to RSS - Australia